Primary Site >> Colorectal Cancer

Gene >> POC1A

Journal: Future Oncol. 2015;11(10):1471-8.
Title: The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer.
Author: Nakamura, Masato|Yamada, Yasuhide|Muro, Kei|Takahashi, Keiichi|Baba, Hideo|Sasaki, Yasutsuna|Komatsu, Yoshito|Satoh, Taroh|Mishima, Hideyuki|Watanabe, Masahiko|Sakata, Yuh|Morita, Satoshi|Shimada, Yasuhiro|Sugihara, Kenichi
PMID: 25963425